Virginia Retirement Systems Et Al Acadia Pharmaceuticals Inc Transaction History

Virginia Retirement Systems Et Al

$10.1 Billion
Q3 2023

A detailed history of Virginia Retirement Systems Et Al transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 42,300 shares of ACAD stock, worth $789,741. This represents 0.01% of its overall portfolio holdings.

Number of Shares

42,300

Previous 57,400 26.31%

Holding current value

$789,741

Previous $1.37 Million 35.88%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jan 02, 2024	SELL	$20.84 - $33.47 $314,684 - $505,397	-15,100 Reduced 26.31%	42,300 $881,000
Q2 2023 Aug 22, 2023	BUY	$17.8 - $25.65 $350,660 - $505,305	19,700 Added 52.25%	57,400 $1.37 Million
Q1 2023 Jul 11, 2023	BUY	$16.32 - $20.92 $135,456 - $173,636	8,300 Added 28.23%	37,700 $709,000
Q4 2022 May 17, 2023	SELL	$14.2 - $18.63 $61,060 - $80,109	-4,300 Reduced 12.76%	29,400 $468 Million
Q3 2022 May 16, 2023	SELL	$14.11 - $18.27 $26,809 - $34,713	-1,900 Reduced 5.34%	33,700 $551 Million
Q1 2022 Apr 21, 2022	SELL	$20.94 - $27.5 $41,880 - $55,000	-2,000 Reduced 5.32%	35,600 $862,000
Q4 2021 Feb 03, 2022	BUY	$16.79 - $27.09 $3,358 - $5,418	200 Added 0.53%	37,600 $878,000
Q3 2021 Oct 21, 2021	BUY	$15.78 - $24.77 $105,726 - $165,959	6,700 Added 21.82%	37,400 $621,000
Q2 2021 Aug 13, 2021	BUY	$19.4 - $27.42 $318,160 - $449,688	16,400 Added 114.69%	30,700 $749,000
Q1 2021 Apr 30, 2021	BUY	$25.02 - $54.99 $42,534 - $93,483	1,700 Added 13.49%	14,300 $369,000
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $619,704 - $857,529	-15,100 Reduced 54.51%	12,600 $674,000
Q3 2020 Nov 12, 2020	SELL	$36.42 - $57.0 $109,260 - $171,000	-3,000 Reduced 9.77%	27,700 $1.14 Million
Q2 2020 Aug 12, 2020	BUY	$39.26 - $52.73 $129,558 - $174,009	3,300 Added 12.04%	30,700 $1.49 Million
Q1 2020 May 12, 2020	BUY	$31.65 - $46.87 $661,485 - $979,583	20,900 Added 321.54%	27,400 $1.16 Million
Q4 2019 Jan 27, 2020	BUY	$36.21 - $51.4 $235,365 - $334,100	6,500 New	6,500 $278,000

Others Institutions Holding ACAD

# of Institutions

281

Shares Held

158M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.02B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Account

Virginia Retirement Systems Et Al Acadia Pharmaceuticals Inc Transaction History